VIDEO: Progressive MS trial failures provide lessons for future success

NEW ORLEANS – Findings last year from the ORATORIO trial showed for the first time that a pharmaceutical agent – ocrelizumab – was effective for slowing the rate of progression in patients with...

Source: Clinical Neurology News - February 23, 2016 Category: Neurology Source Type: news